MAZE - Maze Therapeutics Quarterly EPS earnings growth

Maze Therapeutics, Inc. (MAZE) - corporate logo

The growth of Maze Therapeutics Inc (MAZE) is driven by the Compass AI system and powerful cloud computing for molecular analysis. On GURU.Markets, the quarterly EPS change scale confirms this progress, where the -26.30 metric determines this level. The business remains independent of economic cycles, relying on scientific breakthroughs, while the stability of Western law minimizes geopolitical risks for gene development.

mazetx.com (MAZE) Year-over-year earnings per one share growth for the last 12 months: for the period 02/01/2025 - 11/18/2026

Analytical breakdowns for Maze Therapeutics Inc (MAZE)

- share price and expert price forecast:
Comprehensive company analysis:Maze Therapeutics, Inc., MAZE
Manufactured product of Maze Therapeutics Corp

Investors use this indicator to assess the scaling rate of net income, as the metric measures the percentage change in earnings per share on a quarterly basis. By analyzing the quarterly EPS trend profile, one can identify hidden risks of drawdowns between reporting periods. For Maze Therapeutics Inc (MAZE), such volatility reflects the costs of developing genetic medicine, where the efficiency of utilizing big data in drug discovery correlates directly with final returns.

Competitor analysis

TEM: Quarterly EPS earnings growth|Qiagen Corp - Year-over-year earnings per one share growth for the last 12 months|IONS (Ionis Pharmaceuticals) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RGEN (Repligen)|Quarterly EPS earnings growth RNA|CRSP (CRISPR Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth WGS (GeneDx Holdings Corp.)|RARE: Year-over-year earnings per share growth for the last 12 months|BEAM - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months sarepta.com|TWST: Quarterly EPS earnings growth|TXG - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Intellia|Earnings per share growth in annualized terms for the last twelve months Stoke Therapeutics STOK|Quarterly EPS earnings growth BLFS|Wave Life Sciences - Year-over-year earnings per share growth for the last 12 months|sionnatx.com - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PRME|TSHA - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months uniQure Corp|meiragtx.com (MGTX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months RGNX|Year-over-year net earnings per share growth for the last 12 months SLDB|Quarterly EPS earnings growth Ocugen Inc|Year-over-year earnings per share growth for the last twelve months PacBio Corp (PACB)|Year-over-year net earnings per share change for the last twelve months Benitec Corp|Quarterly EPS earnings growth DSGN (Design Therapeutics, Inc.)|Quarterly EPS earnings growth rocketpharma.com RCKT|4DMT - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Lexeo Therapeutics, Inc.|Korro Bio (KRRO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months EDIT|SLN (Silence Therapeutics plc) - Quarterly EPS earnings growth|proqr.com (PRQR) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CDXS (Codexis Bio)|SGMO - Earnings per share growth in annualized terms for the last twelve months|Nautilus Biotechnology, Inc. - Year-over-year net earnings per share growth for the last 12 months|Net earnings per share growth for the trailing year Metagenomi, Inc|Precision BioSciences - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year generationbio.com (GBIO)|Boundless Bio Inc (BOLD) - Year-over-year earnings per share growth for the last twelve months|Exicure Inc. - Year-over-year earnings per one share growth for the last 12 months|IMNN (imunon.com) - Quarterly EPS earnings growth|Phio Pharmaceuticals - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Mustang Bio Corp (MBIO)|Quarterly EPS earnings growth TransCode (RNAZ)|Quarterly EPS earnings growth BNGO (bionanogenomics.com)|APDN (Applied DNA Sciences Inc) - Year-over-year net earnings per share trend for the last twelve months|BLUE - Year-over-year earnings per share growth for the last twelve months|ImmunoPrecise Antibodies Ltd. (IPA) - Year-over-year net earnings per share growth for the last 12 months|OMGA (Omega) - Year-over-year net earnings per share growth for the last 12 months|singulargenomics.com (OMIC) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months RGLS|Syros (SYRS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months telesisbio.com (TBIO)|TCON - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth UBX (Unity Biotechnology Inc.)